Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vitality Biopharma Inc Ordinary Shares VBIO

Malachite Innovations Inc is dedicated to improving the health and wellness of people and the planet. Its operating subsidiary seeks to advance novel cannabinoid-glycoside compounds created using its proprietary enzymatic bioprocessing technologies to develop safe and effective novel treatments for chronic and debilitating conditions, with an initial focus on inflammatory bowel disease. Its other subsidiary seeks to identify, invest and reposition challenging environmental situations with a focus on technological innovations and eco-friendly solutions deployed in economically challenged communities.


OTCPK:VBIO - Post by User

Post by JMark80on Jul 18, 2018 12:32pm
287 Views
Post# 28333370

Another questionable Avtar Dhillon company

Another questionable Avtar Dhillon company~$50 mm cap fully diluted for a capital constrained company that has no products in clinical development. They're also under investigation by the SEC and have employed questionable promotion tactics, both as Vitality and Stevia First. They have patents, but there are many ways to increase solubility, not just glycosylation.
Bullboard Posts
Next >>